Global Human Serum Market, Forecast Till 2025

  • Category : Healthcare and Pharma
  • |
  • ID : 898157
  • |
  • Date : April-2019
  • |
  • No of Pages: 121
  • |
  • Publisher : Intellectual Research Partners

The global Human Serum market was valued at USD XX million in 2017, and is expected to grow at a CAGR of XX% during the forecast period. The substance that is obtained from blood plasma after fibrinogen and other clotting factors have been separated is known as human serum. Human serum can be obtain from single or multiple donors.
The global human serum market is primarily driven due to increasing demand of human serum sample in growing fields like research & development sectors and technological innovations. In addition, wide range of applications by the increase prevalence of chronic diseases also fuels the market growth. However the high cost of the product might hamper the growth of the market.
Human Serum Market is categorized on the basis of product type, applications, end users and region. On the basis of product type market is divided as pooled human serum, single donor human serum and others. On the basis of applications market is segmented into Scientific Research, Industrial Production and others. Human Serum market end users divided as Pharmaceutical industries, Biopharmaceutical and Biotechnology industries, Academic and Research others.
Based on region the market is segmented into North America, Europe, Asia Pacific, South America and Middle East & Africa.
Some of the prominent players operating in this market include Tissue Culture Biologicals, Gene Tex, Biological Industries, Millipore, Sigma-Aldrich, SeraCare, Merck Innovative Research, Gemini Bio-Products, Valley Biomedical, Biocell Medicare and others.
Key Benefits of the Report:
* Global, Regional, Country, Type and Application market size and forecast from 2014-2025
* Detailed market dynamics, industry outlook with market specific PESTLE, Value Chain, Supply Chain, and SWOT Analysis to better understand the market and build strategies
* Identification of key companies that can influence this market on a Global and regional scale
* Expert interviews and their insights on market shift, current and future outlook and factors impacting vendors short term and long term strategies
* Detailed insights on emerging regions, type, and dosage form and competitive landscape with qualitative and quantitative information and facts
Target Audience:
* Human Serum manufacturers
* Traders, Importer and Exporter
* Raw material suppliers and distributors
* Research and consulting firms
* Government and research organizations
* Associations and industry bodies

Research Methodology
The market is derived through extensive use of secondary, primary, in-house research followed by expert validation and third party perspective like analyst report of investment banks. The secondary research forms the base of our study where we conducted extensive data mining, referring to verified data sources such as white papers government and regulatory published materials, technical journals, trade magazines, and paid data sources.

For forecasting, regional demand & supply factor, investment, market dynamics including technical scenario, consumer behavior, and end use industry trends and dynamics , capacity Route of administration of molecule, spending were taken into consideration.
We have assigned weights to these parameters and quantified their market impacts using the weighted average analysis to derive the expected market growth rate.
The market estimates and forecasts have been verified through exhaustive primary research with the Key Industry Participants (KIPs) which typically include:
* Original Manufacturer,
* Supplier,
* Distributors,
* Government Body & Associations, and
* Research Institute

TABLE OF CONTENTS

1. Introduction

2. Research Methodology

3. Executive Summary

4. Global Human Serum Market Overview
4.1. Market Segmentation & Scope
4.2. Market Trends
4.2.1. Drivers
4.2.1.1. Driver 1
4.2.1.2. Driver 2
4.2.2. Restraints
4.2.2.1. Restraint 1
4.2.3. Opportunities
4.2.3.1. Opportunity 1
4.2.4. Supply Chain Analysis
4.3. Market Share Analysis/Top Player Positioning
4.4. Global Human Serum Market - Porter\'s five forces analysis
4.5. Global Human Serum Market - PESTEL analysis

5. Global Human Serum Market by Type
5.1. Global Human Serum Market, size and forecast
5.2. Global Pooled Human Serum Market
5.2.1. Growth factors and opportunities
5.2.2. Market size and forecast
5.3. Global Single Donor Human Serum Market
5.3.1. Growth factors and opportunities
5.3.2. Market size and forecast

6. Global Human Serum Market by Application
6.1. Global Human Serum Market, size and forecast
6.2. Global Scientific Research Market
6.2.1. Market size and forecast
6.3. Global Industrial Production Market
6.3.1. Market size and forecast

7. Global Human Serum Market by End User
7.1. Global Human Serum Market, size and forecast
7.2. Global Bio-Pharmaceutical companies Market
7.2.1. Market size and forecast
7.3. Global Pharmaceutical Companies Market
7.3.1. Market size and forecast
7.4. Global Academic and Research centers Market
7.4.1. Market size and forecast
7.5. Global Other Markets
7.5.1. Market size and forecast

8. Global Human Serum Market by Region
8.1. Human Serum Market Regional Analysis
8.2. Global Human Serum Market Revenue (USD Million) by Region, 2014-2025
8.3. North America Human Serum Market
8.3.1. North America Human Serum Market Analysis
8.3.2. North America Human Serum Market (Revenue), 2014-2025
8.3.3. North America Human Serum Market by Country, 2014-2025
8.3.3.1. U.S. Human Serum Market (Revenue), 2014-2025
8.3.3.2. Canada Human Serum Market (Revenue), 2014-2025
8.3.4. Europe Human Serum Market by Country, 2014-2025
8.3.4.1. Germany Human Serum Market (Revenue), 2014-2025
8.3.4.2. France Human Serum Market (Revenue), 2014-2025
8.3.4.3. Italy Human Serum Market (Revenue), 2014-2025
8.3.4.4. UK Human Serum Market (Revenue), 2014-2025
8.3.4.5. Spain Human Serum Market (Revenue), 2014-2025
8.3.4.6. Rest of Europe Human Serum Market (Revenue), 2014-2025
8.3.5. Asia Pacific Human Serum Market by Country, 2014-2025
8.3.5.1. Japan Human Serum Market (Revenue), 2014-2025
8.3.5.2. China Human Serum Market (Revenue), 2014-2025
8.3.5.3. India Human Serum Market (Revenue), 2014-2025
8.3.5.4. South Korea Human Serum Market (Revenue), 2014-2025
8.3.5.5. Australia Human Serum Market (Revenue), 2014-2025
8.3.5.6. Rest of Asia Pacific Human Serum Market (Revenue), 2014-2025
8.3.6. South America Human Serum Market by Country, 2014-2025
8.3.6.1. Mexico Human Serum Market (Revenue), 2014-2025
8.3.6.2. Brazil Human Serum Market (Revenue), 2014-2025
8.3.6.3. Argentina Human Serum Market (Revenue), 2014-2025
8.3.6.4. Rest of South America Human Serum Market (Revenue), 2014-2025
8.3.7. Middle East & Africa Human Serum Market by Country, 2014-2025
8.3.7.1. Saudi Arabia Human Serum Market (Revenue), 2014-2025
8.3.7.2. South Africa Human Serum Market (Revenue), 2014-2025
8.3.7.3. Turkey Human Serum Market (Revenue), 2014-2025
8.3.7.4. Rest of Middle East & Africa Human Serum Market (Revenue), 2014-2025

9. Competitive Landscape
9.1. Introduction

10. Company Profiles
10.1. Tissue Culture Biologicals
10.1.1. Company Overview
10.1.2. Financial Overview
10.1.3. Product Benchmarking
10.1.4. Key Developments
10.2. Gene Tex
10.2.1. Company Overview
10.2.2. Financial Overview
10.2.3. Product Benchmarking
10.2.4. Key Developments
10.3. Biological Industries
10.3.1. Company Overview
10.3.2. Financial Overview
10.3.3. Product Benchmarking
10.3.4. Key Developments
10.4. Millipore
10.4.1. Company Overview
10.4.2. Financial Overview
10.4.3. Product Benchmarking
10.4.4. Key Developments
10.5. Sigma-Aldrich
10.5.1. Company Overview
10.5.2. Financial Overview
10.5.3. Product Benchmarking
10.5.4. Key Developments
10.6. SeraCare
10.6.1. Company Overview
10.6.2. Financial Overview
10.6.3. Product Benchmarking
10.6.4. Key Developments
10.7. Gemini Bio-Products
10.7.1. Company Overview
10.7.2. Financial Overview
10.7.3. Product Benchmarking
10.7.4. Key Developments
10.8. Valley Biomedical
10.8.1. Company Overview
10.8.2. Financial Overview
10.8.3. Product Benchmarking
10.8.4. Key Developments
10.9. Merck Innovative Research.
10.9.1. Company Overview
10.9.2. Financial Overview
10.9.3. Product Benchmarking
10.9.4. Key Developments
10.10. Biocell Medicare
10.10.1. Company Overview
10.10.2. Financial Overview
10.10.3. Product Benchmarking
10.10.4. Key Developments

11. Key Insights

Content are not available

Choose License Type